REG - Bellevue Healthcare - Share buy-back programme

Bellevue Healthcare TrustAnnouncement

19/09/2025 11:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250919:nRSS0807Aa&default-theme=true

RNS Number : 0807A  Bellevue Healthcare Trust PLC  19 September 2025

Bellevue Healthcare Trust plc

Share buy-back programme

 

Bellevue Healthcare Trust plc (the Company) has entered into an agreement with
J.P. Morgan Securities plc (JPMS plc) under which it has issued an irrevocable
instruction to JPMS plc to manage the Company's ongoing share buyback
programme. JPMS plc will carry out the instruction through the acquisition of
ordinary shares in the Company within pre-set parameters for subsequent
repurchase by the Company.

 

The Company currently has authority remaining to repurchase a maximum of
6,206,054 of its ordinary shares (being its outstanding shareholder
authority). The Company is seeking a renewal of this authority at a general
meeting convened for 29 September 2025.

 

The buyback may be funded from the Company's resources. The Company is unable
to pay a price for any shares pursuant to the buy-back programme which would
equate to a premium on the net asset value per share.

 

The buy-back will be undertaken pursuant the Company's discount management
programme.

 

This arrangement is in accordance with Chapter 9 of the UK Listing Rules and
the Company's general authority to repurchase shares.

 

The Company confirms that it currently has no inside information.

 

 

For further information, please contact:

 

JP Morgan Cazenove (Corporate Broking)              +44 (0) 20
3493 8000

 

William Simmonds / Rupert Budge
                             BBH_JPMC@jpmorgan.com
(mailto:BBH_JPMC@jpmorgan.com)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSFMSUUEISELU